Menu Search
Equities

Bio-Works Technologies AB

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1BD:FRA

Bio-Works Technologies AB

Actions
  • Price (EUR)0.235
  • Today's Change-0.008 / -3.29%
  • Shares traded53.00
  • 1 Year change+262.65%
  • Beta1.3058
Data delayed at least 15 minutes, as of Feb 06 2026 07:09 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Bio-Works Technologies AB is a Sweden-based biotechnology company. The Company designs, develops, manufactures and supplies products for purification and separation of proteins and other molecules for application in areas such as Research and Laboratory, Life Science and Biopharma, as well as Food and Beverage. The Company uses technology based on uses Agarose beads, which are derived from seaweed in the process of liquid chromatography and serve as adsorbers that bind molecules of interest allowing them to be recovered. Its product offerings, marketed under brand names WorkBeads, BabyBio and OptioBio, include Activated Resin for coupling ligands, BabyBio Columns for rapid protein purification and condition screening, Immobilized Metal-ion Affinity Chromatography (IMAC) Resin, Ion Exchange Chromatography (IEX) Resin and OptioBio Glass Columns for small-scale purification and screening, among others.

  • Revenue in SEK (TTM)41.41m
  • Net income in SEK-29.78m
  • Incorporated2013
  • Employees29.00
  • Location
    Bio-Works Technologies ABVirdings alle 18UPPSALA 754 50SwedenSWE
  • Phone+46 856267430
  • Fax+46 812451329
  • Websitehttps://www.bio-works.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.